This page is kept for reference and is not offered to search engines.
Indication
Mvabea, as part of the Zabdeno, Mvabea vaccine regimen, is indicated for active immunisation for prevention of disease caused by Ebola virus (Zaire ebolavirus species) in individuals ≥ 1 year of age (see sections 4.4 and 5.1).
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
European Medicines Agency (EMA), European public assessment reports
Source: European Medicines Agency, EPAR list (imported 10 June 2026).